Journal article · 2023
Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer
Chemistry & Biodiversity, 20(12), e202300806 · Published 1 December 2023 · DOI 10.1002/cbdv.202300806
In brief
“Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer” is a 2023 journal article by Ishani Paul and 2 co-authors, published in Chemistry & Biodiversity. OpenAlex counts 4 citations as of 21 November 2026, which puts it in the top 8% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 4
- Most cited in
- 2024 (2)
- Field-weighted impact
- 0.31
- References
- 81
- Authors
- 3
Abstract
The IL‐6/IL‐6R/gp130 complex serves as a significant indicator of cytokine release syndrome in COVID‐19 and chronic inflammation, increasing the risk of cancer. Therefore, we identified IL‐6Rα as a potential target to block gp130 interaction. Notably, there has been no reception of approval for an orally available drug to serve this purpose, to date. In this… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Paul, I., Roy, A., & Ray, S. (2023). Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer. Chemistry & Biodiversity, 20(12), e202300806. https://doi.org/10.1002/cbdv.202300806
MLA 9
Paul, Ishani, et al. “Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer.” Chemistry & Biodiversity, vol. 20, no. 12, 2023, p. e202300806. https://doi.org/10.1002/cbdv.202300806.
Chicago
Paul, Ishani, Alankar Roy, and Sujay Ray. 2023. “Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer.” Chemistry & Biodiversity 20 (12): e202300806. https://doi.org/10.1002/cbdv.202300806.
Harvard
Paul, I., Roy, A. and Ray, S. (2023) ‘Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer’, Chemistry & Biodiversity, 20(12), p. e202300806. doi:10.1002/cbdv.202300806.
IEEE
I. Paul, A. Roy, and S. Ray, “Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer,” Chemistry & Biodiversity, vol. 20, no. 12, p. e202300806, 2023, doi: 10.1002/cbdv.202300806.
BibTeX
@article{paul2023molecular,
title = {{Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer}},
author = {Paul, Ishani and Roy, Alankar and Ray, Sujay},
journal = {Chemistry \& Biodiversity},
year = {2023},
volume = {20},
number = {12},
pages = {e202300806},
doi = {10.1002/cbdv.202300806},
url = {https://doi.org/10.1002/cbdv.202300806}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- IL-6 receptor alpha
- gp130
- cytokine release syndrome
- COVID-19 pandemic
- cancer
- pharmacophore modeling
- scaffold hopping
- phytochemicals
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Paul, I., Roy, A., & Ray, S. (2023). Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer. Chemistry & Biodiversity, 20(12), e202300806. https://doi.org/10.1002/cbdv.202300806
How many times has this paper been cited?
4 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Ishani Paul, Alankar Roy, Sujay Ray.
What is the DOI of this paper?
10.1002/cbdv.202300806, permanently at https://doi.org/10.1002/cbdv.202300806. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.